We are live on ! Find out more
NI

Natural Investments Portfolio holdings

AUM $455M
1-Year Est. Return 27.07%
This Fund
S&P 500
This Quarter Est. Return
-3.02%
1 Year Est. Return
+27.07%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$405M
AUM Growth
+$3.62M
Cap. Flow
+$22.9M
Cap. Flow %
5.65%
Top 10 Hldgs %
33.37%
Holding
304
New
24
Increased
127
Reduced
117
Closed
16

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$3.83M
2
NXTE icon
AXS Green Alpha ETF
NXTE
+$1.99M
3
BFAM icon
Bright Horizons
BFAM
+$1.41M
4
ACN icon
Accenture
ACN
+$744K
5
LULU icon
lululemon athletica
LULU
+$741K

Sector Composition

Rank Sector Weight
1 Technology 26.74%
2 Financials 13.2%
3 Healthcare 9.76%
4 Industrials 6.84%
5 Communication Services 4.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CNI icon
151
Canadian National Railway
CNI
$76.6B
$534K 0.13%
5,202
-81
-2% -$8.35K
TMO icon
152
Thermo Fisher Scientific
TMO
$220B
$533K 0.13%
1,085
-3
-0.3% -$1.63K
GPN icon
153
Global Payments
GPN
$22.8B
$532K 0.13%
7,908
-664
-8% -$49K
GE icon
154
GE Aerospace
GE
$384B
$523K 0.13%
1,846
+202
+12% +$63.5K
WAT icon
155
Waters Corp
WAT
$39.9B
$522K 0.13%
1,755
+147
+9% +$50.3K
CI icon
156
Cigna
CI
$74.6B
$516K 0.13%
1,936
-25
-1% -$6.92K
CVSB icon
157
Calvert Ultra-Short Investment Grade ETF
CVSB
$238M
$509K 0.13%
10,077
-89
-0.9% -$4.52K
SPGI icon
158
S&P Global
SPGI
$120B
$508K 0.13%
1,196
+2
+0.2% +$929
T icon
159
AT&T
T
$163B
$505K 0.12%
17,423
+1,659
+11% +$44.3K
TMUS icon
160
T-Mobile US
TMUS
$190B
$504K 0.12%
2,400
+454
+23% +$93.3K
MDT icon
161
Medtronic
MDT
$112B
$503K 0.12%
5,810
+909
+19% +$87.1K
ORCL icon
162
Oracle
ORCL
$423B
$503K 0.12%
3,425
-133
-4% -$21.6K
CL icon
163
Colgate-Palmolive
CL
$74.4B
$485K 0.12%
5,691
+643
+13% +$57.3K
CMCSA icon
164
Comcast
CMCSA
$90B
$483K 0.12%
16,826
+154
+0.9% +$4.61K
BMY icon
165
Bristol-Myers Squibb
BMY
$132B
$478K 0.12%
7,892
+1,221
+18% +$71.2K
SFM icon
166
Sprouts Farmers Market
SFM
$8.01B
$468K 0.12%
6,070
+2,191
+56% +$164K
CRM icon
167
Salesforce
CRM
$158B
$464K 0.11%
2,489
+139
+6% +$28.8K
VTI icon
168
Vanguard Morningstar Total Stock Market ETF
VTI
$691B
$461K 0.11%
1,440
-182
-11% -$61.1K
NUSC icon
169
Nuveen ESG Small-Cap ETF
NUSC
$1.33B
$457K 0.11%
10,147
+425
+4% +$19.8K
MDLZ icon
170
Mondelez International
MDLZ
$79.9B
$451K 0.11%
7,838
+1,277
+19% +$74K
GL icon
171
Globe Life
GL
$14.3B
$445K 0.11%
3,200
-252
-7% -$35.6K
EW icon
172
Edwards Lifesciences
EW
$51.7B
$440K 0.11%
5,500
+588
+12% +$48.5K
KLAC icon
173
KLA
KLAC
$259B
$439K 0.11%
2,990
-20
-0.7% -$2.93K
OEF icon
174
iShares S&P 100 ETF
OEF
$20.5B
$439K 0.11%
1,381
DXCM icon
175
DexCom
DXCM
$32B
$438K 0.11%
+6,984
New +$486K

Similar funds

Natural Investments's Q1 2026 Portfolio in Review

As of Q1 2026, Natural Investments held 304 positions worth $405M, up 0.9% from $402M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Natural Investments deployed $22.9M of net new capital in Q1 2026, opening 24 new positions and adding to 127 existing holdings. Its largest new stake was Nextpower Inc: 12,277 shares worth $1.48M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was AXS Green Alpha ETF, an estimated $1.99M trimmed.

  • Natural Investments's largest Q1 2026 buy was Nextpower Inc: 12,277 shares worth $1.48M.
  • Natural Investments added most to VanEck Green Bond ETF in Q1 2026, an estimated $5.65M increase.
  • Natural Investments's biggest Q1 2026 reduction was AXS Green Alpha ETF, cutting an estimated $1.99M.
  • Natural Investments fully exited AstraZeneca in Q1 2026, selling an estimated $3.83M.
  • Natural Investments's ten largest holdings make up 33% of its $405M portfolio in Q1 2026.
  • Natural Investments opened 24 new positions and closed 16 in Q1 2026.
  • Natural Investments's portfolio value rose 0.9% quarter-over-quarter to $405M.

Based on Natural Investments's 13F filing for Q1 2026, filed 1 May 2026.